BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 16143265)

  • 1. Long-term observation after simultaneous lung and intra-bone marrow-bone marrow transplantation.
    Kaneda H; Adachi Y; Saito Y; Ikebukuro K; Machida H; Suzuki Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Wang J; Imamura H; Ikehara S
    J Heart Lung Transplant; 2005 Sep; 24(9):1415-23. PubMed ID: 16143265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells.
    Fukui J; Inaba M; Ueda Y; Miyake T; Hosaka N; Kwon AH; Sakaguchi Y; Tsuda M; Omae M; Kamiyama Y; Ikehara S
    Stem Cells; 2007 Jun; 25(6):1595-601. PubMed ID: 17446564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic intrabone marrow-bone marrow transplantation plus donor lymphocyte infusion suppresses growth of colon cancer cells implanted in skin and liver of rats.
    Koike Y; Adachi Y; Suzuki Y; Iwasaki M; Koike-Kiriyama N; Minamino K; Nakano K; Mukaide H; Shigematsu A; Kiyozuka Y; Tubura A; Kamiyama Y; Ikehara S
    Stem Cells; 2007 Feb; 25(2):385-91. PubMed ID: 17284650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new strategy for treatment of malignant tumor: intra-bone marrow-bone marrow transplantation plus CD4- donor lymphocyte infusion.
    Suzuki Y; Adachi Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Ikehara S
    Stem Cells; 2005 Mar; 23(3):365-70. PubMed ID: 15749931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy for malignant tumors using combination of allogeneic intra-bone marrow-bone marrow transplantation, donor lymphocyte infusion and dendritic cells.
    Mukaide H; Adachi Y; Koike-Kiriyama N; Suzuki Y; Minamino K; Iwasaki M; Tsuda M; Nakano K; Koike Y; Shigematsu A; Kamiyama Y; Ikehara S
    Int J Oncol; 2007 Jun; 30(6):1309-15. PubMed ID: 17487350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of injection of bone marrow cells into both portal vein and bone marrow on tolerance induction in transplantation of allogeneic pancreatic islets.
    Ikebukuro K; Adachi Y; Suzuki Y; Iwasaki M; Nakano K; Koike Y; Mukaide H; Yamada Y; Fujimoto S; Seino Y; Oyaizu H; Shigematsu A; Kiriyama N; Hamada Y; Kamiyama Y; Ikehara S
    Bone Marrow Transplant; 2006 Nov; 38(10):657-64. PubMed ID: 17013428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term donor-specific tolerance in rat cardiac allografts by intrabone marrow injection of donor bone marrow cells.
    Guo K; Inaba M; Li M; An J; Cui W; Song C; Wang J; Cui Y; Sakaguchi Y; Tsuda M; Omae M; Ando Y; Li Q; Wang X; Feng W; Ikehara S
    Transplantation; 2008 Jan; 85(1):93-101. PubMed ID: 18192918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
    J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
    Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
    J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
    Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
    J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic intra-BM-BMT plus adult thymus transplantation from same donor has benefits for long-term survival even after sublethal irradiation or low-dose BM cell injection.
    Nishida T; Hosaka N; Takaki T; Miyake T; Cui W; Inaba M; Kinoshita H; Matsuda T; Ikehara S
    Bone Marrow Transplant; 2009 Jun; 43(11):829-37. PubMed ID: 19079314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful allogeneic leg transplantation in rats in conjunction with intra-bone marrow injection of donor bone marrow cells.
    Esumi T; Inaba M; Ichioka N; Kushida T; Iida H; Ikehara S
    Transplantation; 2003 Dec; 76(11):1543-8. PubMed ID: 14702521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of correlation between an assay used to determine early marrow allograft rejection and long-term chimerism after murine allogeneic bone marrow transplantation: effects of marrow dose.
    Koh CY; Welniak LA; Murphy WJ
    Biol Blood Marrow Transplant; 2005 Apr; 11(4):252-9. PubMed ID: 15812390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
    Zhu ZX; Fan LY; Wang Q
    Eur Surg Res; 2011; 46(3):109-17. PubMed ID: 21242693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of GVHD by intra-bone marrow bone marrow transplantation plus donor lymphocyte infusion.
    Nakamura K; Inaba M; Sugiura K; Yoshimura T; Kwon AH; Kamiyama Y; Ikehara S
    Stem Cells; 2004; 22(2):125-34. PubMed ID: 14990852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell transplantation for autoimmune diseases: what can we learn from experimental models?
    Ikehara S
    Autoimmunity; 2008 Dec; 41(8):563-9. PubMed ID: 18958757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts.
    Li S; Salgar SK; Thanikachalam M; Murdock AD; Gammie JS; Demetris AJ; Zeevi A; Pham SM
    J Surg Res; 2006 Dec; 136(2):238-46. PubMed ID: 17046021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New strategies for allogeneic BMT.
    Ikehara S
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S73-5. PubMed ID: 12931248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.